Background Respiratory syncytial virus (RSV) is the most important viral cause of
pneumonia in children. RSV-specific antibody (ab) protects infants from disease, and may
be increased by a potential strategy of maternal RSV vaccination. Objectives To describe the
effect of RSV antibody on RSV infection risk in infants in a resource-limited setting. Study
design In a prospective study in Nepal, women were enrolled during pregnancy and
maternal and infant cord blood were collected at birth. Weekly surveillance for respiratory�…